ASH 2025 – Latebreaker
From Hämatologie Shortcasts by Dr. med. Richard Schabath, Dr. med. Andreas Hausmann, Dr. med. Stephan Fuhrmann
December 4, 2025 · 34 min · Season 4 · Episode 15
About this episode
The episode discusses the latest findings from the ASH Congress, focusing on innovative therapies and studies in hematology.
People in this episode
Hosts: Dr. Richard Schabath, Dr. Andreas Hausmann
Guests: Lucy Fox, Simon Harrison, Wojciech Jurczak
Topics covered
- Latebreaking Abstracts
- CAR-T-Zelltherapien
- multiple Myelom
- ITP
- CLL
- genetic studies
- therapeutic strategies
Keywords
- ASH 2025
- Latebreaker
- CAR-T therapy
- genetic disorders
- multiple myeloma
- CLL
- ITP
- clinical relevance
Mentioned in this episode
Organizations: ASH-Kongress, IBM DX Study, Diamond-Blackfan-Anämie, KLN1010, Pirtoproteinib, Vendamustin-Rituximab, CLL, Myelom, ITP
More episodes of Hämatologie Shortcasts
- Zwischen ASH und ASCO: Praxisrelevante Updates aus Lymphom, AML und Myelofibrose · June 11, 2026 · 18 min
- AML – Revolution oder Evolution? · February 27, 2026 · 26 min
- ASH 2025 - Aggressive B-Zell-Lymphome: Neue Optionen für ältere Patient:innen, Zelltherapien und Monitoring · February 5, 2026 · 18 min
- ASH 2025 – T-Zell-Lymphome: Neue Targets, frühe Rezidive und klinische Konsequenzen · January 19, 2026 · 29 min
- ASH 2025 – Epcoritamab & Co.: Wie sich die Therapie des follikulären Lymphoms verändert · December 19, 2025 · 20 min
- ASH 2025 - AML im Umbruch? · December 17, 2025 · 33 min
Explore listener stats, chart rankings, contacts and more on the Hämatologie Shortcasts podcast page.